ImmuPharma (LSE:IMM) Gross-Profit-to-Asset % : 3.86% (As of Jun. 2023)

ImmuPharma Gross-Profit-to-Asset % Chart

ImmuPharma Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
Gross-Profit-to-Asset %		Get a 7-Day Free Trial					1.18	1.08	1.52	1.40	-

ImmuPharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															0.53	2.91	-	-	3.86

Competitive Comparison of ImmuPharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, ImmuPharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmuPharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmuPharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where ImmuPharma's Gross-Profit-to-Asset % falls into.

ImmuPharma Gross-Profit-to-Asset % Calculation

ImmuPharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

ImmuPharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

ImmuPharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of ImmuPharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuPharma (LSE:IMM) Business Description